| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President and CEO | Chief Operating Officer
2 companies
Ciaffoni Joseph serves as a Chief Executive Officer at INDV and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 40 sells. Those positions are worth an estimated $30.3M at current prices.
Historically, Ciaffoni Joseph's trades have earned a below-average insider score of 43/100 across 23 rated trades. Over a 12-month horizon, 13.0% of those trades were profitable, with an average 12-month return of -20.3%.
The biggest single holding is INDV (~$30.3M) as Chief Executive Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE10b5-1 | 4,357 | $30.38 | $132,376.55 | -1.6% | +27.3% | -2.5% | |
| Dec 20, 2023 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE10b5-1 | 68,768 | $30.18 | $2,075,086.31 | -20.0% | +27.3% | +2.0% | |
| Jun 2, 2023 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell10b5-1 | 62,544 | $21.84 | $1,366,181.82 | -18.5% | +8.3% | +53.2% | |
| May 31, 2023 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell10b5-1 | 62,543 | $21.88 | $1,368,703.50 | -15.6% | +7.9% | +46.9% | |
| Feb 13, 2023 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 11,250 | $26.88 | $302,400.00 | -2.7% | -12.8% | +19.4% | |
| Dec 27, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell | 2,461 | $23.67 | $58,251.60 | -1.0% | +2.5% | +30.7% | |
| Dec 21, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell | 17,842 | $23.08 | $411,840.22 | -6.6% | +8.2% | +32.4% | |
| Dec 2, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 131,053 | $22.72 | $2,977,400.91 | -32.8% | +18.2% | +11.2% | |
| Nov 28, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 43 | $22.00 | $946.00 | - | +24.9% | +18.9% | |
| Nov 22, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 65 | $22.00 | $1,430.00 | - | +18.2% | +18.4% |